partial and total knee and hip Arthoplasty, pain management and mobility - Nursing Case Study

Pathophysiology

• Primary mechanism: Osteoarthritis leads to cartilage degradation in the knee and hip joints, causing bone-on-bone friction and severe pain, necessitating partial or total arthroplasty to replace the damaged joint surfaces with prosthetic components.

• Secondary mechanism: Post-operative inflammation and swelling occur due to tissue trauma from surgery, triggering nociceptors that exacerbate pain and hinder mobility. Effective pain management, often involving multimodal analgesia, is crucial to optimize recovery and facilitate early mobilization.

• Key complication: Prosthetic joint infection, though rare, poses a severe risk as it can result in systemic infection and prosthesis failure. Vigilant monitoring for signs of infection and prompt intervention are essential to prevent further complications and ensure successful rehabilitation.

Patient Profile

Demographics:

68-year-old female, retired nurse

History:

• Key past medical history: Osteoarthritis, hypertension, type 2 diabetes, obesity, history of DVT

• Current medications: Metformin, Lisinopril, Warfarin, Hydrocodone/Acetaminophen, Gabapentin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe pain and limited mobility in both knees and hips following recent arthroplasty surgeries

• Key symptoms: Swelling and redness around surgical sites, difficulty in weight-bearing, fever, increased fatigue

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 39.2°C (102.6°F), oxygen saturation 88% on room air

Section 1

New Complications:

Several days post-discharge, the patient presents to the emergency department with worsening clinical symptoms that raise concerns for systemic infection. On examination, the surgical sites on both the knee and hip exhibit increased erythema, warmth, and purulent drainage. The patient reports escalating pain that is unresponsive to her current analgesic regimen. Notably, her fever has persisted, and she feels profoundly fatigued, with difficulty performing basic activities of daily living. Her vital signs are alarming: blood pressure has dropped to 130/85 mmHg, heart rate has climbed to 125 bpm, respiratory rate remains elevated at 26 breaths per minute, and oxygen saturation has decreased to 85% on room air. These findings suggest a potential systemic inflammatory response or sepsis, likely secondary to prosthetic joint infection.

Laboratory investigations reveal a significant leukocytosis with a white blood cell count of 18,000/µL, elevated C-reactive protein (CRP) levels, and an erythrocyte sedimentation rate (ESR) that is markedly high, suggesting acute inflammation. Blood cultures have been drawn and are pending results, but initial urinalysis is unremarkable. The patient's renal function is compromised, with a serum creatinine level of 1.8 mg/dL, indicating acute kidney injury possibly exacerbated by dehydration and medication effects. An urgent orthopedic consultation is sought for evaluation of potential surgical intervention, while an infectious disease specialist is consulted to initiate broad-spectrum intravenous antibiotics, pending culture results.

This development presents a complex clinical scenario requiring integrated management of infection control, hemodynamic stabilization, and pain management. The multidisciplinary team must weigh the risks and benefits of potential revision surgery versus aggressive medical management. The patient's history of DVT and current anticoagulation therapy with Warfarin adds another layer of complexity, necessitating careful coordination to mitigate bleeding risks while addressing the underlying infection. The next steps involve closely monitoring her clinical response to the initiated treatments, adjusting her medication regimen to optimize pain control and renal function, and ensuring sufficient oxygenation and ventilation support. This situation demands advanced critical thinking to navigate the intricacies of her care plan and improve her overall prognosis.

Section 2

As the multidisciplinary team initiates treatment, the patient’s response to interventions becomes the focal point of her care. Within 24 hours of starting broad-spectrum intravenous antibiotics, there is a slight improvement in her fever, which decreases to 100.5°F from a previous 102.8°F. However, her respiratory distress persists, with oxygen saturation remaining at 87% on supplemental oxygen via nasal cannula at 2 L/min. Despite initial fluid resuscitation efforts, her blood pressure continues to trend downward, now reading 115/75 mmHg, raising concerns about her hemodynamic stability. The patient's heart rate remains elevated at 120 bpm, suggesting unresolved systemic stress.

Simultaneously, the orthopedic and infectious disease teams deliberate over the risk-benefit profile of a potential surgical intervention. The decision is made to proceed with a joint aspiration procedure to obtain synovial fluid for culture and sensitivity testing, aiming to tailor antibiotic therapy more precisely. Preliminary results from blood cultures indicate the presence of Gram-positive cocci in clusters, suggestive of Staphylococcus aureus, pending further specification. The patient's renal function shows no significant improvement, with serum creatinine stable at 1.8 mg/dL, necessitating careful adjustment of antibiotic dosing to prevent further nephrotoxicity.

The complexity of the patient's condition is further compounded by her coagulation status. Given her history of DVT and ongoing anticoagulation therapy with Warfarin, INR monitoring is critical to balance the risk of bleeding against thromboembolic complications. Her INR is currently 2.5, aligning with therapeutic range but requiring vigilant surveillance as surgical considerations progress. The team must exhibit advanced critical thinking as they reassess and refine the patient’s care plan, considering the potential need for anticoagulation reversal if surgical debridement becomes imperative. This scenario highlights the need for ongoing, dynamic evaluation of the patient’s evolving clinical picture, ensuring that interventions are timely and appropriately targeted to improve outcomes.

Section 3

As the clinical team continues to monitor the patient's condition, new diagnostic results reveal further complexities in her case. The synovial fluid culture confirms the presence of Methicillin-resistant Staphylococcus aureus (MRSA), necessitating a shift in antibiotic therapy to Vancomycin. However, the adjustment in medication poses additional challenges due to the patient's renal impairment, as her creatinine levels remain steady at 1.8 mg/dL, indicating compromised kidney function. The nephrology team is consulted to provide guidance on dosing adjustments to mitigate the risk of nephrotoxicity, while ensuring effective antimicrobial coverage.

Additionally, the patient's respiratory status deteriorates, with an increase in respiratory rate to 30 breaths per minute and oxygen saturation dropping further to 85% despite escalation of oxygen therapy to 4 L/min via nasal cannula. A chest X-ray is ordered, revealing bilateral infiltrates suggestive of pneumonia, complicating her clinical picture and requiring the initiation of respiratory support measures. The team deliberates the potential need for non-invasive ventilation or even intubation, balancing the risks associated with her coagulation status and potential for bleeding.

Meanwhile, the patient's hemodynamic status continues to be a concern, as her blood pressure now reads 105/68 mmHg with a persistent heart rate of 125 bpm despite ongoing fluid therapy. The critical care team is brought in to evaluate the necessity for vasopressor support to maintain perfusion and prevent further organ dysfunction. The multidisciplinary team remains focused on integrating these new findings into a cohesive care plan, prioritizing interventions that address the patient's respiratory distress, infection control, and hemodynamic instability, all while closely monitoring her coagulation profile to ensure safety in the event of surgical intervention.

Section 4

As the clinical team continues to grapple with the complexities of the patient's condition, new diagnostic results further illuminate the challenges at hand. Blood cultures drawn earlier in the patient's admission have returned positive for MRSA bacteremia, underscoring the urgency of effective antimicrobial management. This finding necessitates a reassessment of the patient's infection control protocols and prompts the infectious disease specialist to advocate for heightened isolation measures to prevent cross-contamination. Concurrently, renal function tests reveal a slight but significant increase in the patient's creatinine level to 2.0 mg/dL, intensifying concerns about the nephrotoxic potential of Vancomycin therapy. The nephrology team recommends a revised dosing schedule, incorporating extended intervals between doses to accommodate her compromised renal clearance while maintaining therapeutic drug levels.

Meanwhile, the patient's respiratory status undergoes a concerning change. Despite the escalation to non-invasive ventilation, her oxygen saturation remains precariously low at 82%, and her work of breathing shows no signs of improvement. Arterial blood gas analysis reveals a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 58 mmHg, indicating acute respiratory acidosis secondary to hypoventilation. The respiratory therapist and critical care physician concur that intubation may be imminent, particularly given the risk of rapid deterioration. However, the patient's coagulation profile, with an INR of 2.1, raises the specter of bleeding complications during intubation, necessitating careful preparation and meticulous technique.

Faced with these evolving challenges, the multidisciplinary team convenes to integrate the latest findings into a cohesive care strategy. Prioritizing the patient's respiratory support, they carefully weigh the benefits and risks of intubation, considering the potential need for sedation, the implications for her hemodynamic stability, and the risk of exacerbating her infection. Simultaneously, they explore adjunctive strategies such as bronchodilator therapy and physiotherapy to optimize her pulmonary status. With renal function closely monitored and infection control measures reinforced, the team remains vigilant, ready to adapt their approach as new developments arise in this complex case.

Section 5

As the multidisciplinary team continues to navigate the patient's complex condition, a new complication surfaces that demands immediate attention. During a routine assessment, the nursing staff notes a sudden onset of altered mental status. The patient, previously alert and oriented, now exhibits confusion, disorientation, and agitation. Vital signs reveal a blood pressure of 145/95 mmHg, heart rate of 110 beats per minute, respiratory rate of 28 breaths per minute, and a fluctuating oxygen saturation ranging from 78% to 85% on non-invasive ventilation. A quick bedside glucose check rules out hypoglycemia as a cause, suggesting the need for further investigation into this acute change in neurological status.

A STAT head CT is ordered to rule out acute intracranial events, given the patient's anticoagulation therapy and elevated INR, which could predispose her to hemorrhagic complications. Concurrently, the team considers the possibility of septic encephalopathy or delirium secondary to her ongoing MRSA bacteremia and the stress of her critical illness. The recent arterial blood gas analysis indicating respiratory acidosis further complicates the picture, as CO2 retention could contribute to her altered mental state. The nephrology team re-evaluates the patient's renal function, now showing a creatinine level climbing to 2.3 mg/dL, raising concerns about ongoing renal impairment and necessitating adjustments to medication dosages, particularly those with central nervous system side effects.

In response to these developments, the team intensifies their focus on optimizing the patient's hemodynamic and respiratory stability while ensuring rigorous monitoring of her neurological status. They initiate a low-dose dexmedetomidine infusion to address agitation without compromising respiratory drive, carefully balancing sedation needs with the risk of exacerbating respiratory depression. As they await the head CT results, the team remains poised to escalate care, including potential intubation, should her mental status or respiratory condition deteriorate further. This evolving situation demands relentless clinical vigilance and adaptive problem-solving, as each new piece of data could pivot the patient's management trajectory significantly.